Literature DB >> 16766653

Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo.

Grégory Scherrer1, Petra Tryoen-Tóth, Dominique Filliol, Audrey Matifas, Delphine Laustriat, Yu Q Cao, Allan I Basbaum, Andrée Dierich, Jean-Luc Vonesh, Claire Gavériaux-Ruff, Brigitte L Kieffer.   

Abstract

The combination of fluorescent genetically encoded proteins with mouse engineering provides a fascinating means to study dynamic biological processes in mammals. At present, green fluorescent protein (GFP) mice were mainly developed to study gene expression patterns or cell morphology and migration. Here we used enhanced GFP (EGFP) to achieve functional imaging of a G protein-coupled receptor (GPCR) in vivo. We created mice where the delta-opioid receptor (DOR) is replaced by an active DOR-EGFP fusion. Confocal imaging revealed detailed receptor neuroanatomy throughout the nervous system of knock-in mice. Real-time imaging in primary neurons allowed dynamic visualization of drug-induced receptor trafficking. In DOR-EGFP animals, drug treatment triggered receptor endocytosis that correlated with the behavioral response. Mice with internalized receptors were insensitive to subsequent agonist administration, providing evidence that receptor sequestration limits drug efficacy in vivo. Direct receptor visualization in mice is a unique approach to receptor biology and drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766653      PMCID: PMC1480468          DOI: 10.1073/pnas.0603359103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking.

Authors:  L Kallal; J L Benovic
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

Review 2.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

3.  Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization.

Authors:  C M Cahill; K A McClellan; A Morinville; C Hoffert; D Hubatsch; D O'Donnell; A Beaudet
Journal:  J Comp Neurol       Date:  2001-11-05       Impact factor: 3.215

4.  Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.

Authors:  D Filliol; S Ghozland; J Chluba; M Martin; H W Matthes; F Simonin; K Befort; C Gavériaux-Ruff; A Dierich; M LeMeur; O Valverde; R Maldonado; B L Kieffer
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

5.  Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia.

Authors:  Ji-Song Guan; Zhen-Zhong Xu; Hua Gao; Shao-Qiu He; Guo-Qiang Ma; Tao Sun; Li-Hua Wang; Zhen-Ning Zhang; Isabelle Lena; Ian Kitchen; Robert Elde; Andreas Zimmer; Cheng He; Gang Pei; Lan Bao; Xu Zhang
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

6.  Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation.

Authors:  J A Trafton; C Abbadie; K Marek; A I Basbaum
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

7.  Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

Authors:  H Wang; V M Pickel
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

8.  Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.

Authors:  C M Cahill; A Morinville; M C Lee; J P Vincent; B Collier; A Beaudet
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

9.  Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.

Authors:  Stephen P Hack; Elena E Bagley; Billy C H Chieng; MacDonald J Christie
Journal:  J Neurosci       Date:  2005-03-23       Impact factor: 6.167

10.  Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

Authors:  G Feng; R H Mellor; M Bernstein; C Keller-Peck; Q T Nguyen; M Wallace; J M Nerbonne; J W Lichtman; J R Sanes
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

View more
  122 in total

Review 1.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Increased abundance of opioid receptor heteromers after chronic morphine administration.

Authors:  Achla Gupta; Jan Mulder; Ivone Gomes; Raphael Rozenfeld; Ittai Bushlin; Edmund Ong; Maribel Lim; Emeline Maillet; Mats Junek; Catherine M Cahill; Tibor Harkany; Lakshmi A Devi
Journal:  Sci Signal       Date:  2010-07-20       Impact factor: 8.192

4.  Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment.

Authors:  Dongman Chao; Qinyu Wang; Gianfranco Balboni; Guanghong Ding; Ying Xia
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

Review 5.  Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications.

Authors:  Mark von Zastrow
Journal:  Drug Alcohol Depend       Date:  2010-03-24       Impact factor: 4.492

6.  Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn.

Authors:  Rita Bardoni; Vivianne L Tawfik; Dong Wang; Amaury François; Carlos Solorzano; Scott A Shuster; Papiya Choudhury; Chiara Betelli; Colleen Cassidy; Kristen Smith; Joriene C de Nooij; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; C Jeffrey Woodbury; Allan I Basbaum; Amy B MacDermott; Grégory Scherrer
Journal:  Neuron       Date:  2014-02-27       Impact factor: 17.173

7.  A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action.

Authors:  Miriam Stoeber; Damien Jullié; Braden T Lobingier; Toon Laeremans; Jan Steyaert; Peter W Schiller; Aashish Manglik; Mark von Zastrow
Journal:  Neuron       Date:  2018-05-10       Impact factor: 17.173

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Oligomerization of G-protein-coupled receptors: a reality.

Authors:  Sergi Ferré; Rafael Franco
Journal:  Curr Opin Pharmacol       Date:  2009-12-16       Impact factor: 5.547

10.  The influences of reproductive status and acute stress on the levels of phosphorylated delta opioid receptor immunoreactivity in rat hippocampus.

Authors:  Suzanne R Burstein; Tanya J Williams; Diane A Lane; Margarete G Knudsen; Virginia M Pickel; Bruce S McEwen; Elizabeth M Waters; Teresa A Milner
Journal:  Brain Res       Date:  2013-04-11       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.